Integrated in vivo genetic and pharmacologic screening identifies co-inhibition of EGRF and ROCK as a potential treatment regimen for triple-negative breast cancer
综合体内遗传和药理学筛选确定 EGRF 和 ROCK 的联合抑制是治疗三阴性乳腺癌的潜在方案
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.10230
Sedef Iskit, Cor Lieftink, Pasi Halonen, Aida Shahrabi, Patricia A Possik, Roderick L Beijersbergen, Daniel S Peeper
